Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia

Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN).

Journal of endocrinological investigation·2024

Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.

Annals of hematology·2018

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

Leukemia·2016

Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.

Leukemia & lymphoma·2016

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Leukemia & lymphoma·2016

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Haematologica·2026

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

Crosstalk Between Oligodendrocyte Lineage Cells and CNS-Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis.

Glia·2026

Autophagy: Mechanisms and therapeutic perspectives in intestinal metaplasia (Review).

Molecular medicine reports·2026

Diffuse Large B-Cell Lymphoma Masquerading as Cholangiocarcinoma in a Young Adult.

ACG case reports journal·2026

Prognostic Outcomes in Seropositive and Seronegative Autoimmune Encephalitis.

Iranian journal of child neurology·2026

Related Experiment Videos

Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia

Related Concept Videos

Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Crosstalk Between Oligodendrocyte Lineage Cells and CNS-Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis.

Autophagy: Mechanisms and therapeutic perspectives in intestinal metaplasia (Review).

Diffuse Large B-Cell Lymphoma Masquerading as Cholangiocarcinoma in a Young Adult.

Prognostic Outcomes in Seropositive and Seronegative Autoimmune Encephalitis.

Related Experiment Videos

Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia

Related Concept Videos

Related Articles